Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Wellcome Trust launches open-access publishing venture

    Jul 13, 2016, 08:16 AM by Michael Croft
    Nature News & Comment | Wellcome Open Research is meant to allow Wellcome grant recipients to publish their findings more quickly. The charity hopes other funders will follow a similar model. Management of the venture will be contracted to F1000Research.
    Full story
  • Genomic Medicine Training, New Storage Options, Food Allergy Science

    Jul 12, 2016, 15:10 PM by Michael Croft
    Bio-IT World | News and product launches from around the Bio-IT landscape include a postdoctoral fellowship in genomics medicine in Alabama, a synthetic biology partnership, new Lustre storage, and the Broad's food allergy science institute.
    Full story
  • A Drug For Postpartum Depression? Sage Passes Early Test With Experimental Treatment

    Jul 12, 2016, 14:48 PM by Michael Croft
    Forbes | Encouraging news is out today for the treatment of severe postpartum depression. Sage Therapeutics, a biotech company in Cambridge, Mass., reported that its experimental drug was able to relieve severe symptoms of postpartum depression for 70% of patients within a few days, and keep them in remission for a month.
    Full story
  • Danforth Plant Science Center and Valent BioSciences will Collaborate in Unique Root Science Initiative

    Jul 12, 2016, 13:07 PM by Michael Croft
    ST. LOUIS, MO, UNITED STATES - Jul 12, 2016 - Valent BioSciences Corporation (VBC) and the Donald Danforth Plant Science Center today announced the finalization of a multi-year, Master Cooperation Agreement in the area of root science and the rhizosphere
    Full story
  • Crop Roots Enact Austerity Measures During Drought to Bank Water

    Jul 11, 2016, 17:29 PM by Michael Croft
    ST. LOUIS, UNITED STATES - Jul 11, 2016 - With a growing world population and a changing climate, understanding how agriculturally important plants respond to drought is crucial
    Full story
  • Intel's Cancer Cloud: Complementing NCI Collaboration

    Jul 11, 2016, 13:25 PM by Michael Croft
    Bio-IT World | Intel may have missed out on a major government grant, but that hasn't stopped it from developing a collaborative cloud for genomicists and bioinformaticians that it wanted to build all along.
    Full story
  • IT spending will shrink worldwide due to Brexit Gartner predicts

    Jul 8, 2016, 08:47 AM by Michael Croft
    Computerworld | Britain's vote to exit the European Union will depress global IT spending, according to Gartner analyst John-David Lovelock.
    Full story
  • Juno Therapeutics Stops Trial Of Cancer-Killing Cells After 3 Patient Deaths

    Jul 8, 2016, 08:38 AM by Michael Croft
    Forbes | Three patients have died in a closely watched study of using genetically engineered white blood cells to treat adult leukemia patients, forcing the trial to be put on hold. The news is a blow for Juno Therapeutics, the biotechnology startup valued at $4.3 billion.
    Full story
  • Siemens Investment Accelerates Launch of Riffyn’s Ground-breaking R&D Design Software

    Jul 8, 2016, 07:37 AM by Michael Croft
    OAKLAND, CA, UNITED STATES - Jul 8, 2016 - Riffyn, Inc. announces an investment by Siemens Venture Capital to accelerate the launch of its cloud-based research process design software
    Full story
  • Obama Seeks To Make Mark On Genetic Medicine

    Jul 7, 2016, 11:05 AM by Michael Croft
    Forbes | After a few weeks of hype around the Obama administration's efforts to speed cancer research, officials tonight announced plans to kickstart efforts around the president's Precision Medicine Initiative.
    Full story
  • Cloud Adoption Numbers Are All Over the Map

    Jul 7, 2016, 10:07 AM by Michael Croft
    Fortune | Johnson & Johnson turned off its last mainframe and plans to move 85% of its software to the cloud. Is it mainstream or an outlier?
    Full story
  • Recipharm appoints new General Manager in Research Triangle Park, USA

    Jul 7, 2016, 07:34 AM by Michael Croft
    RESEARCH TRIANGLE PARK, NC - Jul 7, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), has appointed Ann Flodin as General Manager of its wholly owned new subsidiary Recipharm Laboratories Inc
    Full story
  • Pfizer Might Buy Bind Therapeutics From Bankruptcy for $20M

    Jul 6, 2016, 13:02 PM by Michael Croft
    Xconomy | Bind Therapeutics and its treatment for treatment for non-small cell lung cancer may soon be owned by one-time partner Pfizer. Bind, which filed for Chapter 11 bankruptcy in May asked the court to approve a bid from Pfizer on July 1.
    Full story
  • Non-profit Research Accelerator SAVE JON Relaunches as Curable

    Jul 6, 2016, 09:43 AM by Michael Croft
    PITTSBURGH, PA - Jul 6, 2016 - SAVE JON, a non-profit research accelerator that applies engineering approaches to medicine, today announced that it is relaunching as Curable
    Full story
  • Owning Your Data: The Genos Model

    Jul 6, 2016, 05:45 AM by Michael Croft
    Bio-IT World | Consumer genomics startup, Genos, is expanding its beta program and inviting Bio-IT World readers to sequence their whole exome at CLIA-certified 75x coverage for $399.
    Full story
  • Recipharm increases blow fill seal capacity in Kaysersberg, France

    Jul 5, 2016, 10:55 AM by Michael Croft
    STOCKHOLM, SWEDEN - Jul 5, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), has announced an €18 million investment to expand its blow fill seal (BFS) capacity at its site in Kaysersberg, FranceThe investment will see the introduction of a new blow fill seal high speed filling and packaging line, bringing the total number of lines from seven to eight to meet growing demand for the service
    Full story
  • ZENITH TECHNOLOGIES APPOINTS SERIALIZATION DIRECTOR

    Jul 5, 2016, 09:52 AM by Michael Croft
    - Jul 5, 2016 - A global life science technology firm, with headquarters in Ireland, has appointed Carlos Machado as serialization director to lead the company’s sales, operations, implementation and post project support services in the US
    Full story
  • Building Amgen’s RWD Platform

    Jul 1, 2016, 10:35 AM by Michael Croft
    Bio-IT World | Best Practices Amgen built a Real World Data platform to provide an enterprise-wide capability to better access and analyze available claims, electronic health records (EHRs), and cohort data, and address questions across the clinical and health IT development lifecycle.
    Full story
  • PrecisionFDA Announces Truth Challenge Winners

    Jun 29, 2016, 16:10 PM by Michael Croft
    Bio-IT World  PrecisionFDA announced the results of its Truth Challenge today. Entries from Verily Life Sciences, Kinghorn Center for Clinical Genomics, and Sanofi-Genzyme won top recognition. In addition to the winners, DNAnexus, Roche, Real Time Genomics, Sentieon, Qunitiles, Macrogen, the Broad Institute, and others participated.
    Full story
  • New Investments, Projects Spur Moonshot Program Forward

    Jun 29, 2016, 14:45 PM by Michael Croft
    Bio-IT World The Cancer Moonshot Summit today served as a platform for many announcements from both the public and private sectors on ways to advance the Moonshot’s goals.
    Full story
  • «
  • 341
  • 342
  • 343
  • 344 (current)
  • 345
  • 346
  • 347
  • 348
  • 349
  • 350
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy